Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2026)

Sarepta Therapeutics' Change in Inventory history runs 11 years deep, the most recent figure standing at $69.8 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 60.67% year-over-year to $69.8 million in Q1 2026; TTM through Mar 2026 was $193.5 million, a 62.21% decrease from a year earlier, with the FY2025 full-year figure at $301.1 million, down 23.81% from the prior year.
• Change in Inventory advanced to $69.8 million in Q1 2026 per SRPT's latest filing, from -$18.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $177.4 million in Q1 2025 and bottomed at -$18.5 million in Q4 2025.
• The 5-year median for Change in Inventory is $59.2 million (2025), against an average of $56.7 million.
• Across the five-year window, Change in Inventory surged 19675.16% in 2024 and plunged 111.43% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $8.9 million in 2022, then soared by 959.73% to $94.1 million in 2023, then jumped by 71.79% to $161.7 million in 2024, then plunged by 111.43% to -$18.5 million in 2025, then surged by 477.57% to $69.8 million in 2026.
• Per Business Quant, the three latest SRPT Change in Inventory figures stand at $69.8 million (Q1 2026), -$18.5 million (Q4 2025), and $83.0 million (Q3 2025).